Serial 97981632
Live / Applied — Statement of use — processing complete, to examiner (as of 19 Nov 2026)
What this means for you
Not registered yet, but its 21 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97981632
- Mark type
- Design / logo
- Kind
- Trademark
- Register
- Principal
- Basis
- Intent to use (§1(b))
- Filed
- 21 Apr 2023
- Published for opposition
- 13 May 2025
- Examining attorney
- Sasha Rios
- Attorney of record
- Michele H. Bowman
Goods and services
- Class 010 — Medical apparatus: Medical apparatus and instruments for monitoring and managing diabetes, namely, biosensors, sensors for measuring analyte concentrations in interstitial fluid, sensors for monitoring analyte levels in interstitial fluid, sensors for monitoring analyte concentrations in bodily fluids, sensors for monitoring analyte levels in bodily fluids, readers for use with sensors for monitoring analyte concentrations, readers for use with sensors for monitoring analyte levels in bodily fluids, applicators for sensors worn by a human, applicators for biosensors worn by a human; medical devices worn by a human for monitoring glucose levels; readers and applicators for use with medical devices worn by a human for monitoring glucose levels; medical devices for monitoring biological analytes; readers and applicators for use with medical devices for monitoring biological analytes; sensors for medical use to be worn by a human to gather physiological data; readers and applicators for use with sensors for medical use to be worn by a human to gather physiological data; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for health and medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for health and medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; sensor-based medical apparatus that tracks, gathers, measures, monitors, and determines biological analyte concentrations and analyte data for use in medical analysis; medical apparatus and instruments for use in monitoring and managing glucose levels; medical apparatus and instruments for use in monitoring and managing biological analyte levels in fluids; medical devices, namely, patient monitors and patient sensors for monitoring, measuring, and managing biological analyte concentrations in bodily fluids in the field of health for health and medical purposes; medical apparatus and instruments for determination of analyte concentrations for health and medical purposes; electrochemical sensors that track, gather, measure, monitor, and determine biological analyte concentrations and analyte data for health and medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes and applicators and readers for use with such electrochemical sensors for health and medical purposes; medical apparatus for monitoring biological analyte levels in interstitial fluid; continuous glucose monitoring systems featuring electrochemical sensors for determination of glucose concentrations in bodily fluids for medical purposes
Owner
- Abbott Diabetes Care Inc., Alameda, CA, US
- Abbott Diabetes Care Inc., Alameda, CA, US
Prosecution history
- 19 Nov 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jul 2026 — USE AMENDMENT FILED
- 19 Nov 2026 — DIVISIONAL PROCESSING COMPLETE
- 08 Jul 2026 — DIVISIONAL REQUEST RECEIVED
- 19 Nov 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jul 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2026 — SOU EXTENSION 1 GRANTED
- 06 Jan 2026 — SOU EXTENSION 1 FILED
- 06 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 May 2025 — PUBLISHED FOR OPPOSITION